Proteomic analysis of the Trypanosoma cruzi ribosomal proteins

Maximiliano Juri Ayub1, James Atwood, Arthur Nuccio

  • 1Laboratorio de Biología Molecular de la Enfermedad de Chagas, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI-CONICET), Buenos Aires, Argentina.

Insights

Investigating Trypanosoma cruzi, the parasite causing Chagas disease, revealed unique ribosomal protein structures. These findings offer potential new targets for developing crucial anti-parasitic chemotherapy.

Area of Science:

  • Molecular Biology
  • Parasitology
  • Biochemistry

Background:

  • Chagas disease, caused by the parasite Trypanosoma cruzi, poses a significant public health challenge.
  • Identifying novel chemotherapeutic targets is essential for effective disease control.
  • The translational system in trypanosomatids, including T. cruzi, exhibits unique characteristics compared to other eukaryotes, though detailed knowledge is limited.

Purpose of the Study:

  • To conduct a comprehensive analysis of ribosomal protein genes in Trypanosoma cruzi.
  • To characterize the T. cruzi ribosomal proteome using mass spectrometry.
  • To identify potential differences in ribosomal proteins that could be exploited for drug development.

Main Methods:

  • Bioinformatic data mining of the T. cruzi genome database for ribosomal protein genes.
  • Mass spectrometry analysis of purified T. cruzi ribosomes.
  • Comparative sequence analysis of T. cruzi ribosomal proteins against eukaryotic homologs (e.g., yeast).

Main Results:

  • Trypanosoma cruzi ribosomal proteins share approximately 50% sequence identity with yeast ribosomal proteins.
  • Several T. cruzi ribosomal proteins possess unique N- or C-terminal extensions not found in other eukaryotes.
  • Specific examples include C-terminal extensions in L19 (168 amino acids) and S21 (164 amino acids).
  • Two 60S ribosomal subunit proteins, L22 and L42, were identified in the T. cruzi proteome for the first time.

Conclusions:

  • The ribosomal protein composition of Trypanosoma cruzi exhibits distinct features, including unique extensions.
  • These parasite-specific structural variations represent potential targets for novel anti-parasitic drug development.
  • Further research into the T. cruzi translational machinery could lead to effective Chagas disease therapies.

Related Concept Videos

Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...